National Bank of Canada’s Agilon Health AGL Stock Holding History

National Bank of Canada’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Hold	0	–	-$2	–	2834
2025 Q2	–	Hold	0	–	–	–	2963
2025 Q1	–	Sell	-56	Closed	-$4.87K	–	2814
2024 Q4	$2.65K	Buy	56 +28	+100%	+$1.69K	﹤0.01%	2546
2024 Q3	$2.79K	Buy	+28	New	+$3.62K	﹤0.01%	2315
2023 Q4	–	Sell	-43	Closed	-$19.5K	–	2712
2023 Q3	$19.5K	Buy	43 +1	+2%	+$452	﹤0.01%	2051
2023 Q2	$18.3K	Buy	42 +13	+45%	+$7.31K	﹤0.01%	2026
2023 Q1	$17K	Hold	29	–	–	﹤0.01%	2014
2022 Q4	$11.7K	Buy	29 +1	+4%	+$469	﹤0.01%	2142
2022 Q3	$16K	Buy	28 +21	+300%	+$12.6K	﹤0.01%	2068
2022 Q2	$4K	Buy	7 +6	+600%	+$3.04K	﹤0.01%	2448
2022 Q1	$1K	Hold	1	–	–	﹤0.01%	2758
2021 Q4	$1K	Buy	+1	New	+$608	﹤0.01%	2725

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

National Bank of Canada's AGL Position: Q3 2025 in Review

National Bank of Canada held its Agilon Health (AGL) position steady in Q3 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

National Bank of Canada first reported a position in AGL in Q4 2021 and has held it in 10 quarters since. The position peaked at $19.5K in Q3 2023. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

National Bank of Canada held 0 shares of Agilon Health worth $0 as of Q3 2025.
National Bank of Canada left its Agilon Health share count unchanged in Q3 2025.
Agilon Health made up ﹤0.01% of National Bank of Canada's portfolio in Q3 2025, its #2834 holding.
National Bank of Canada first reported a position in Agilon Health in Q4 2021 and has held it in 10 quarters since.
National Bank of Canada's Agilon Health position peaked at $19.5K in Q3 2023.
190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.